Kenvue Inc
KVUE
Detailliertes Diagramm anzeigen
16.770USD
-0.110-0.65%
Handelsschluss 11/10, 16:00（ET）Kurse um 15 Minuten verzögert
32.13BMarktkapitalisierung
22.42KGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
-0.65%
5 Tage
+3.90%
1 Monat
+0.72%
6 Monate
-31.38%
Seit Jahresbeginn
-21.45%
1 Jahr
-29.18%
Detailliertes Diagramm anzeigen
TradingKey Aktienbewertung von Kenvue Inc
Währung: USD Aktualisiert: 2025-11-10Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ gesund. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Halten bewertet. Trotz einer durchschnittlichen Aktienmarktperformance zeigt das Unternehmen starke Fundamentaldaten und technische Indikatoren. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Kenvue Inc Bewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
15
Analysten
Halten
Aktuelles Rating
19.701
Kursziel
+16.71%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Kenvue Inc Highlights
HöhepunkteRisiko
Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
high_dividend
high_dividend_desc%!(EXTRA string=150.68%)
valuation_reasonable
valuation_reasonable_desc%!(EXTRA string=PE, string=22.43)
institutional_decreasing_position
institutional_decreasing_position_desc%!(EXTRA string=1.94B, string=13.23%)
institutional_hold%!(EXTRA string=Lee Ainslie)
institutional_hold_desc%!(EXTRA string=Lee Ainslie, string=10.41M)
Kenvue Inc Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
Kenvue Inc Informationen
Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
BörsenkürzelKVUE
UnternehmenKenvue Inc
CEOMr. Kirk L. Perry
Websitehttps://www.kenvue.com
Verwandte Finanzinstrumente
-1.01%
-1.07%
-0.37%
-0.73%
+2.14%
-2.56%
-2.49%
-0.57%
-3.93%
+0.63%
-0.72%
-0.60%
-1.07%
-5.33%
-0.39%
-0.14%
-0.51%
+1.39%
-2.53%Beliebte Symbole
